S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
NYSE:JPM

JPMorgan Chase & Co. (JPM) Price Target & Analyst Ratings

$154.45
+0.89 (+0.58%)
(As of 08/11/2023 08:48 PM ET)
Compare
Today's Range
$152.63
$154.52
50-Day Range
$138.60
$158.00
52-Week Range
$101.28
$159.38
Volume
5.18 million shs
Average Volume
11.86 million shs
Market Capitalization
$448.84 billion
P/E Ratio
9.94
Dividend Yield
2.59%
Price Target
$164.39

JPMorgan Chase & Co. Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 18 Analyst Ratings

Consensus Analyst Price Target

$164.39
6.44% Upside
High Prediction$192.00
Average Prediction$164.39
Low Prediction$132.00
TypeCurrent
8/14/22 to 8/14/23
1 Month Ago
7/15/22 to 7/15/23
3 Months Ago
5/16/22 to 5/16/23
1 Year Ago
8/14/21 to 8/14/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
9 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$164.39$158.94$157.06$145.95
Predicted Upside6.44% Upside18.70% Upside19.85% Upside21.00% Upside
Get JPMorgan Chase & Co. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for JPM and its competitors with MarketBeat's FREE daily newsletter.


JPM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

JPM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

JPMorgan Chase & Co. Stock vs. The Competition

TypeJPMorgan Chase & Co.Finance CompaniesS&P 500
Consensus Rating Score
2.67
2.41
2.48
Consensus RatingModerate BuyHoldHold
Predicted Upside6.44% Upside951.05% Upside13.47% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/1/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$150.00 ➝ $160.00+1.29%
7/18/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$160.00 ➝ $173.00+12.62%
7/17/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$158.00 ➝ $168.00+12.30%
7/17/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$174.00 ➝ $180.00+20.18%
7/17/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$160.00 ➝ $170.00+13.51%
7/16/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$179.00 ➝ $182.00+21.52%
7/12/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$160.00+8.50%
7/11/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$149.00 ➝ $165.00+13.62%
7/10/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
7/7/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform$170.00+18.71%
6/26/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/12/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$155.00 ➝ $151.00+10.99%
5/2/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$169.00 ➝ $170.00+20.40%
5/1/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
4/17/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperformer$157.00 ➝ $192.00+38.87%
4/17/2023Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$131.00 ➝ $155.00+12.11%
4/17/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$152.00 ➝ $158.00+13.89%
4/14/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$160.00 ➝ $172.00+23.98%
3/24/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$150.00 ➝ $132.00+4.07%
1/13/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Erika Najarian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$156.00+10.19%
1/6/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$155.00 ➝ $145.00+7.13%
(Data available from 8/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












JPM Price Target - Frequently Asked Questions

What is JPMorgan Chase & Co.'s consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for JPMorgan Chase & Co. stock is Moderate Buy based on the current 6 hold ratings and 12 buy ratings for JPM. The average twelve-month price prediction for JPMorgan Chase & Co. is $164.39 with a high price target of $192.00 and a low price target of $132.00. Learn more on JPM's analyst rating history.

Do Wall Street analysts like JPMorgan Chase & Co. more than its competitors?

Analysts like JPMorgan Chase & Co. more than other Finance companies. The consensus rating for JPMorgan Chase & Co. is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how JPM compares to other companies.

Is JPMorgan Chase & Co. being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, JPMorgan Chase & Co.'s stock had 2 upgrades and 2 downgrades by analysts.

Does JPMorgan Chase & Co.'s stock price have much upside?

According to analysts, JPMorgan Chase & Co.'s stock has a predicted upside of 16.97% based on their 12-month price targets.

What analysts cover JPMorgan Chase & Co.?
Does JPMorgan Chase & Co. rate other companies?

JPMorgan Chase & Co. also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.


Stock Ratings Reports and Tools

This page (NYSE:JPM) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -